Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia
Journal of Clinical Endocrinology and Metabolism | Oct 18, 2021
Most read this week
Journal of Clinical Endocrinology and Metabolism | Oct 18, 2021